Atea Pharmaceuticals Inc.

NASDAQ: AVIR · Real-Time Price · USD
3.50
0.01 (0.29%)
At close: Aug 15, 2025, 3:59 PM
3.50
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT

Atea Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-168.38M -135.96M -115.91M 121.19M
Depreciation & Amortization
416K 416K 260K 29K
Stock-Based Compensation
51.77M 49.43M 46.72M 39.62M
Other Working Capital
-7.68M 14.46M -44.6M -258.13M
Other Non-Cash Items
-11.82M 33.11M -5.46M 29.39M
Deferred Income Tax
n/a -48.56M n/a -29.39M
Change in Working Capital
-7.48M 16.16M -46.59M -247.84M
Operating Cash Flow
-135.5M -85.39M -120.98M -87M
Capital Expenditures
n/a n/a -1.94M -4K
Cash Acquisitions
n/a n/a 453.47K n/a
Purchase of Investments
-461.18M -562.36M -545.35M n/a
Sales Maturities Of Investments
517.28M 602.66M 91.89M n/a
Other Investing Acitivies
n/a n/a -453.47K n/a
Investing Cash Flow
56.1M 40.3M -455.41M -4K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 140K n/a
Financial Cash Flow
267K 257K 370K 1.47M
Net Cash Flow
-79.13M -44.84M -576.02M -85.54M
Free Cash Flow
-135.5M -85.39M -122.92M -87.01M